In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]
- PMID: 31388299
- PMCID: PMC6607975
- DOI: 10.2147/IJN.S217605
In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]
Figures
Erratum for
-
In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.Int J Nanomedicine. 2017 Sep 30;12:7165-7182. doi: 10.2147/IJN.S143529. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29033568 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous